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Introduction
Concepts of good clinical practice
Good clinical practice (GCP) is “a standard for the
design, conduct, performance, monitoring, auditing,
recording, analyses, and reporting of clinical trials”.1
It was developed in response to some serious cases of
fraud and abuse of patients’ rights.2 Since GCP rules
were first made mandatory by the United States (US)
Food and Drug Administration, they have been widely
implemented by regulatory authorities in other coun-
tries, such as those in the European Union, Japan,
Australia, and the member states of the World Health
Organization.3
A guideline for GCP from the recent International
Conference on Harmonization of GCP is now accepted
as a unified standard by regulatory authorities and
pharmaceutical companies in the US, European Union,
and Japan.1 This guideline creates a general scientific
bench-mark for clinical trials research methodology.
The aims of the guideline are to protect study subjects,
and to improve the ethical and scientific qualities of
studies. A higher quality of research ensures the safety
of study subjects and the development of better medi-
cal care and products for patients who are in need of
new therapy. Rules for GCP also provide “a resource
for editors to determine the acceptability of reported
research for publication”.4
Evidence-based medicine
Evidence-based medicine “de-emphasises intuition,
unsystematic clinical experience, and pathophysio-
logic rationale as sufficient grounds for clinical
decision making and stresses the examination of
evidence from clinical research”.5 In other words,
decision making in clinical practice must be based on
research-generated scientific evidence. The strength
of such evidence, however, depends on the ways in
which it has been obtained. One assignment of the
Canadian Task Force on the Periodic Health Exami-
nation was to develop a set of criteria for evaluating
scientific evidence on the effectiveness of any preven-
tive intervention.6 These criteria were reviewed by
the US Preventive Services Task Force which classi-
fied the quality of evidence according to the way it
was collected. Evidence was classed as grade I if it
came from at least one properly randomised control-
led trial; grade II if it came from controlled trials
without randomisation, designed cohort or case-
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control analytic studies, or uncontrolled experiments;
and grade III if from clinical experience or descrip-
tive studies.6 A properly designed randomised clini-
cal trial is the most valid study and when performed
properly, it provides the strongest evidence on which
to make a clinical decision. The medical practice
from this decision will be more beneficial and
favourable.
The need for training
Many investigators and their research staff or associ-
ates are not fully educated about the principles and
practical application of GCP rules.7 Gennery8 stated
that training is one of the most critical areas in the
process of GCP. Training in clinical trials research
methodology that is based on GCP rules should be
mandatory for all investigators and their clinical re-
search staff. It is also important for medical students,
residents, fellows, physicians, graduate students in
health or other related disciplines, and personnel from
the pharmaceutical industry and regulatory authorities.9
Training in GCP teaches these scientists how to im-
prove the standard of clinical trials research.
Productivity is, in part, a function of training and
experience10,11 and can be increased by structured train-
ing in research methodology.12 Developing well-trained
and experienced research staff is vital to the success
of any study. Clinical research training is not usually
emphasised for clinical research faculty members,13
however, and they may even be “often deprived of
valuable training in research methodology”.14
Clinical trials research methodology training
programmes
In many institutions, there are formal and informal
training programmes in clinical trials research
methodology, and GCP rules for clinical research staff
or associates.9,15 These include academic programmes,
training by professional societies, commercial train-
ing programmes, and company training programmes.16
Academic institutions such as the University of
North Carolina, University of Michigan, and Temple
University in the US, and the University of Montreal
in Canada, offer some higher-degree courses in clini-
cal research methodology.9 Professional societies,
including the US Food and Drug Administration, the
American Academy of Allergy and Immunology, and
the Associates of Clinical Pharmacology, sponsor
training programmes for clinical research staff. The
University of Indonesia runs workshops on GCP for
clinicians and industry representatives.16 There are
also some university-affiliated postgraduate fellowship
and residency programmes.17
A clinical trials research training programme should
include research studies and the teaching of current
international GCP standards, and basic approaches to
and methodology of clinical trials. A syllabus for a
training course on clinical trial research methods has
been described by Spilker,9 and contents of suitable
curricula have been proposed.9,14
Study objectives
In Hong Kong, the training of research staff in the
concepts of clinical trials research methodology has
not yet been extensively implemented. The aims of
this study were to define the current knowledge of
GCP rules and clinical trials research methodology,
and to identify any need for a clinical trials research
methodology training programme for various levels
of clinical research staff in Hong Kong.
Materials and methods
A non-random sample of 161 people was asked be-
tween May and August 1996 to answer a standardised
questionnaire. Doctors and clinical research staff
participating at the study were those attending various
workshops or lectures at the Queen Mary and Pamela
Youde Nethersole Eastern hospitals. The study objec-
tives were also described in a letter which was mailed
to 30 pharmaceutical companies in Hong Kong and
an appointment was made if a company agreed to
participate. Eighty-three (51.6%) participants were
doctors and 26 (16.1%) were clinical research staff or
research associates, most of whom worked at the Queen
Mary Hospital. Another 52 (32.3%) participants were
employees from the pharmaceutical industry in Hong
Kong.
The questionnaire consisted of two parts. The
first contained 20 multiple-choice questions on clini-
cal trials research methodology. There were five
choices but only one correct answer for each question.
Most questions concerning GCP rules were based on
the 1990 European GCP guidelines. Questions tested
knowledge in the following areas: basic concepts of
GCP, roles and responsibilities of parties, ethics, data
management, biostatistics, and basic concepts of
clinical trials. In the second part of the questionnaire,
subjects were asked about their willingness to partici-
pate in eight specific courses related to clinical trials
research methodology (yes/no answers). These courses
were about GCP knowledge, information searching,
scientific report writing, study protocol, biostatistics,
computer programmes, quality of life estimates, and
laboratory testing. The list was based on Spilker’s list
of specific clinical research topics.9 Preferences for
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duration of participation in the various programmes
(full time, part time, day time, evening, weekday, or
weekend) were also assessed.
A pilot study based on eight clinical research staff
was performed to ensure the comprehensibility and
completeness of the questionnaire, and modifications
were made accordingly. A simple statistical descrip-
tion of the findings was made using the Statistical
Analysis System for Windows, Release 6.08.18
Results
Current knowledge of clinical trials research
methodology
The Box shows the percentages of correct answers
scored in response to the 20 questions. The question
in which the highest score was achieved was about
the characteristics of an experimental study (55.3%
correct). The lowest score was about countries which
practise GCP rules (9.3% correct).
Percentages of questionnaire respondents answering correctly
Question Respondents, n=161
No. (%)
When was the GCP guideline valid in Europe? 29 (18.0)
Which countries practise the GCP guideline? 15 (9.3)
What are the main objectives of the GCP guideline? 38 (23.6)
What is the meaning of a phase II trial? 25 (15.5)
Who can be a principal investigator? 36 (22.4)
Who should review the study budget? 82 (50.9)
What is the minimum number of members on an Ethics Committee? 43 (26.7)
Which document is not required to be submitted to an Ethics Committee? 20 (12.4)
What kind of persons can be recruited in a clinical study? 58 (36.0)
What information must be supplied to the subject? 85 (52.8)
Who can be an independent witness? 65 (40.4)
What is the characteristic of an experimental study? 89 (55.3)
How should a stratified block randomisation be performed? 52 (32.3)
What are the reasons for undertaking sample size calculation? 70 (43.5)
What are needed for sample size calculation? 65 (40.4)
What are the roles of a biostatistician in a clinical study? 32 (19.9)
What information should be included in a protocol? 17 (10.6)
How should principal investigators make corrections in a case report form? 41 (25.5)
What are the sources of an adverse event? 37 (23.0)
How long should a principal investigator keep study documents? 27 (16.8)
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Figure 1 depicts the frequency distribution of the
total score of correct answers among the 161 study
subjects. The median score of correctly answered
multiple-choice questions was 5 (25%) for the whole
study group. The mode was 4 (20%) which was the
score expected if answers were only random guesses.
Only minor differences were detected in median
correct answers between the three working groups
(range of scores, 5-6). The median number of correct
answers was 6.0 for doctors, 5.5 for research staff, and
5.0 for industry employees.
Preferences for participation in the training
programmes
Figure 2 shows the percentages of people who ex-
pressed interest in various training programmes. The
most popular courses were information searching,
GCP, and scientific report writing; the least popular
was laboratory testing.
Comparison between the three working groups
Figure 3 depicts the interest among the three working
groups (doctors, clinical research staff, and pharma-
ceutical industry employees) in participating in the
various training programmes. There were significant
differences (P<0.05, χ2 test) between the three groups
for courses related to biostatistics, computer pro-
grammes, and quality of life estimates.
Discussion
This study found that there was little knowledge of
GCP rules and clinical trials research methodology
among research staff, and that there is a need for the
introduction of a training programme in clinical trials
research methodology for research staff in Hong Kong.
The study may be criticised on the grounds of not us-
ing a randomised sampling technique. The questions
asked in the questionnaire may also not be the best
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Fig 2. Bar chart showing respondents’ interest in various training programmes
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The Chi squared test was used; P>0.05 for the courses
not named above; results are expressed as mean±SD
way to assess the current knowledge of clinical trials
research methodology. The results, however, demon-
strate researchers’ poor knowledge of clinical trials
research methodology, particularly since the most
frequent score was that expected if answers had been
randomly chosen.
The study also found minor differences among the
three professional groups, namely doctors, research
staff, and industry employees. This may reflect differ-
ences in levels of education in research methodology;
for example, the most traditional method of training is
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by coaching—a method that may be limited due to
workload constraints and lack of qualified mentors.
Since clinical research of different disciplines has much
in common, it would be appropriate to build up a sys-
tematic training programme to address the individual
needs of both experienced and inexperienced research
staff. The training programme should begin before
participation of the researcher in a clinical study, and
should continue throughout that study. All people
involved in clinical trials, particularly those who have
direct contact with subjects, need to understand fully
their responsibilities as defined by rules of GCP. They
should understand how to obtain informed consent
correctly, complete case record forms accurately, and
monitor and record any adverse events properly. This
should result in improved staff performance which will
increase the safety of the study subjects and contrib-
ute to quality data.
This study identified a strong demand for train-
ing programmes related to clinical trials research
methodology. On average, each person expressed an
interest in participating in at least three of the eight
courses listed. Training programmes such as workshops
on the GCP guideline have been held elsewhere in Asia,
for example, Singapore, Indonesia, Malaysia, Thailand,
and the Philippines, and recently in Hong Kong.16
Since 1990, many reports on the ethnic differences
between the Chinese and Caucasian races have been
published. They show there is limited mutual accept-
ance of data from trials carried out in different ethnic
populations.19,20 For example, there are differences
between approved dosages of antihypertensives, anti-
arrhythmics, antibiotics, antibacterials, antivirals, anti-
histamines, and psychotropics, as used in Japan and
in western countries.21 Instead of accepting data on
other ethnic groups, Hong Kong studies would provide
better, more accurate information on the most suitable
regimens and possible side effects for Asian populations.
Ultimately, performing more studies of high quality
will improve the availability of important, new, and
better medical care and products to patients.
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